129
Participants
Start Date
September 1, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
"Nefecon®,Ambrisentan"
"Subjects who meet the screening criteria will be treated with Budesonide in combination with Ambrisentan.~Budesonide (Nefecon®), 16mg/d for 36 weeks, taken orally. Ambrisentan , 5mg/d for 36 weeks, taken orally."
RECRUITING
The First Hospital of Jilin University, Changchun
The First Hospital of Jilin University
OTHER